Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant Medication

Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00460902

Enrollment

Registered

2007-04-17

Start date

2007-04-30

Completion date

2009-08-31

Last updated

2015-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression

Keywords

TMS, drug resistant depression

Brief summary

Evaluation of the novel deep TMS H-Coil design as an augmentation measure in the treatment of medication resistant major depression. Stimulation is administered with and without cognitive-emotional provocation.

Interventions

DEVICETranscranial Magnetic Stimulation (TMS)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients diagnosed as suffering from treatment resistant major depression * Right laterality

Exclusion criteria

* other major axis I diagnosis * severe axis II diagnosis * risk factors to convulsions * history of drug abuse in the past year

Design outcomes

Primary

Measure	Time frame
HAMILTON RATING SCALE FOR DEPRESSION 24 items	4 weeks

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026